SCHEMBL16015689

SCHEMBL16015689

CCOC(=O)C(C)(O)CC(=O)O[C@H]1C[C@@H](C)CC[C@@H]1C(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.48
EPHX1 P07099 2/20 0.47
MAPT P10636 5/20 0.45
NPSR1 Q6W5P4 4/20 0.45
TSHR P16473 3/20 0.45
ALDH1A1 P00352 8/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
TRPM8 Q7Z2W7 1/20 0.44
MAPK1 P28482 4/20 0.44
HPGD P15428 2/20 0.44
KDM4E B2RXH2 1/20 0.44
GAA P10253 1/20 0.44
LMNA P02545 3/20 0.43
USP2 O75604 1/20 0.43
MITF O75030 2/20 0.39
HTT P42858 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 1/20 0.39
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13557795 0.81 CYP19A1 (0.53) CYP19A1EPHX1MAPTNPSR1TSHR
SCHEMBL24249845 0.81 CYP19A1 (0.53) CYP19A1EPHX1MAPTNPSR1TSHR
SCHEMBL13059722 0.80 CYP19A1 (0.41) CYP19A1EPHX1MAPTNPSR1TSHR
SCHEMBL7133227 0.80 CYP19A1 (0.41) CYP19A1EPHX1MAPTNPSR1TSHR
SCHEMBL5556173 0.80 CYP19A1 (0.41) CYP19A1EPHX1MAPTNPSR1TSHR
SCHEMBL1286336 0.78 EPHX1 (0.53) CYP19A1EPHX1MAPTNPSR1TSHR
SCHEMBL16622496 0.78 EPHX1 (0.53) CYP19A1EPHX1MAPTNPSR1TSHR
SCHEMBL18596846 0.78 CYP19A1 (0.60) CYP19A1EPHX1MAPTNPSR1TSHR
SCHEMBL10171231 0.78 CYP19A1 (0.60) CYP19A1EPHX1MAPTNPSR1TSHR
SCHEMBL12952148 0.78 CYP19A1 (0.60) CYP19A1EPHX1MAPTNPSR1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE45128-E1 Cephalotaxane derivatives and their processes of preparation and purification IVAX International GmbH (CH) 2014-09-09 US disclosed